Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4-Amino-1-[5-O-[(2R,4S)-2-oxido-4-(4-pyridinyl)-1,3,2-dioxaphosphorinan-2-yl]--D-arabinofuranosyl]-2(1H)-pyrimidinone

EU orphan designation number: EU/3/07/477   
Active ingredient: 4-Amino-1-[5-O-[(2R,4S)-2-oxido-4-(4-pyridinyl)-1,3,2-dioxaphosphorinan-2-yl]--D-arabinofuranosyl]-2(1H)-pyrimidinone
Indication: Treatment of hepatocellular carcinoma
Sponsor: Interface International Consultancy Limited
Hadhams, Main Street, Huggate, York YO42 IYQ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Centralised Orphan - Designation EMEA/OD/045/07 (2007)4335 of 14/09/2007